150 related articles for article (PubMed ID: 25173640)
1. Expression of BTG1 in hepatocellular carcinoma and its correlation with cell cycles, cell apoptosis, and cell metastasis.
Sun GG; Lu YF; Cheng YJ; Yang CR; Liu Q; Jing SW; Han XC
Tumour Biol; 2014 Dec; 35(12):11771-9. PubMed ID: 25173640
[TBL] [Abstract][Full Text] [Related]
2. BTG1 expression correlates with the pathogenesis and progression of breast carcinomas.
Sheng SH; Zhao CM; Sun GG
Tumour Biol; 2014 Apr; 35(4):3317-26. PubMed ID: 24272202
[TBL] [Abstract][Full Text] [Related]
3. The expression of BTG1 is downregulated in NSCLC and possibly associated with tumor metastasis.
Sun GG; Lu YF; Cheng YJ; Hu WN
Tumour Biol; 2014 Apr; 35(4):2949-57. PubMed ID: 24264312
[TBL] [Abstract][Full Text] [Related]
4. The expression of BTG1 is downregulated in nasopharyngeal carcinoma and possibly associated with tumour metastasis.
Sun GG; Wang YD; Cheng YJ; Hu WN
Mol Biol Rep; 2014 Sep; 41(9):5979-88. PubMed ID: 24985971
[TBL] [Abstract][Full Text] [Related]
5. BTG1 underexpression is an independent prognostic marker in esophageal squamous cell carcinoma.
Sun GG; Wang YD; Cheng YJ; Hu WN
Tumour Biol; 2014 Oct; 35(10):9707-16. PubMed ID: 24969561
[TBL] [Abstract][Full Text] [Related]
6. Abnormal expression and mechanism of miR-330-3p/BTG1 axis in hepatocellular carcinoma.
Zhao X; Chen GQ; Cao GM
Eur Rev Med Pharmacol Sci; 2019 Aug; 23(16):6888-6898. PubMed ID: 31486488
[TBL] [Abstract][Full Text] [Related]
7. BTG1 expression in thyroid carcinoma: diagnostic indicator and prognostic marker.
Lu YF; Sun GG; Liu Q; Yang CR; Cheng YJ
Int J Oncol; 2014 Oct; 45(4):1574-82. PubMed ID: 25017022
[TBL] [Abstract][Full Text] [Related]
8. Increased Expression of SETD7 Promotes Cell Proliferation by Regulating Cell Cycle and Indicates Poor Prognosis in Hepatocellular Carcinoma.
Chen Y; Yang S; Hu J; Yu C; He M; Cai Z
PLoS One; 2016; 11(5):e0154939. PubMed ID: 27183310
[TBL] [Abstract][Full Text] [Related]
9. Overexpressed GNAZ predicts poor outcome and promotes G0/G1 cell cycle progression in hepatocellular carcinoma.
Tian F; Cai D
Gene; 2022 Jan; 807():145964. PubMed ID: 34530087
[TBL] [Abstract][Full Text] [Related]
10. An antiproliferative gene FLNA regulates migration and invasion of gastric carcinoma cell in vitro and its clinical significance.
Sun GG; Sheng SH; Jing SW; Hu WN
Tumour Biol; 2014 Mar; 35(3):2641-8. PubMed ID: 24241900
[TBL] [Abstract][Full Text] [Related]
11. B cell translocation gene 1 reduces the biological outcome of kidney cancer through induction of cell proliferation, cell cycle arrest, cell apoptosis and cell metastasis.
Sun G; Liu Q; Cheng Y; Hu W
Int J Mol Med; 2015 Mar; 35(3):777-83. PubMed ID: 25571854
[TBL] [Abstract][Full Text] [Related]
12. Suppressive effects of microRNA-16 on the proliferation, invasion and metastasis of hepatocellular carcinoma cells.
Wu WL; Wang WY; Yao WQ; Li GD
Int J Mol Med; 2015 Dec; 36(6):1713-9. PubMed ID: 26499886
[TBL] [Abstract][Full Text] [Related]
13. BTG1 expression correlates with pathogenesis, aggressive behaviors and prognosis of gastric cancer: a potential target for gene therapy.
Zheng HC; Li J; Shen DF; Yang XF; Zhao S; Wu YZ; Takano Y; Sun HZ; Su RJ; Luo JS; Gou WF
Oncotarget; 2015 Aug; 6(23):19685-705. PubMed ID: 26050197
[TBL] [Abstract][Full Text] [Related]
14. EMP1 inhibits nasopharyngeal cancer cell growth and metastasis through induction apoptosis and angiogenesis.
Sun GG; Lu YF; Fu ZZ; Cheng YJ; Hu WN
Tumour Biol; 2014 Apr; 35(4):3185-93. PubMed ID: 24292952
[TBL] [Abstract][Full Text] [Related]
15. Prognostic significance of low expression of B-cell translocation gene 1 (
Li G; Yue Y; Li W; Chen Y; Fan H; Yuan J; Chen Z; Liu J
J Biosci; 2020; 45():. PubMed ID: 32457282
[TBL] [Abstract][Full Text] [Related]
16. CD109 Mediates Cell Survival in Hepatocellular Carcinoma Cells.
Zong G; Xu Z; Zhang S; Shen Y; Qiu H; Zhu G; He S; Tao T; Chen X
Dig Dis Sci; 2016 Aug; 61(8):2303-2314. PubMed ID: 27074923
[TBL] [Abstract][Full Text] [Related]
17. High expression of G-protein signaling modulator 2 in hepatocellular carcinoma facilitates tumor growth and metastasis by activating the PI3K/AKT signaling pathway.
He XQ; Zhang YF; Yu JJ; Gan YY; Han NN; Zhang MX; Ge W; Deng JJ; Zheng YF; Xu XM
Tumour Biol; 2017 Mar; 39(3):1010428317695971. PubMed ID: 28347229
[TBL] [Abstract][Full Text] [Related]
18. Identification of LZAP as a new candidate tumor suppressor in hepatocellular carcinoma.
Zhao JJ; Pan K; Li JJ; Chen YB; Chen JG; Lv L; Wang DD; Pan QZ; Chen MS; Xia JC
PLoS One; 2011; 6(10):e26608. PubMed ID: 22028922
[TBL] [Abstract][Full Text] [Related]
19. Fibulin-5 inhibits hepatocellular carcinoma cell migration and invasion by down-regulating matrix metalloproteinase-7 expression.
Tu K; Dou C; Zheng X; Li C; Yang W; Yao Y; Liu Q
BMC Cancer; 2014 Dec; 14():938. PubMed ID: 25494879
[TBL] [Abstract][Full Text] [Related]
20. B‑cell translocation gene 1 serves as a novel prognostic indicator of hepatocellular carcinoma.
Kanda M; Sugimoto H; Nomoto S; Oya H; Hibino S; Shimizu D; Takami H; Hashimoto R; Okamura Y; Yamada S; Fujii T; Nakayama G; Koike M; Fujiwara M; Kodera Y
Int J Oncol; 2015 Feb; 46(2):641-8. PubMed ID: 25405901
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]